Literature DB >> 24332950

Nonstandard glenoid components for bone deficiencies in shoulder arthroplasty.

Akin Cil1, John W Sperling2, Robert H Cofield3.   

Abstract

BACKGROUND: Glenoid bone deficiencies may be addressed by specialized components. The purpose of this study is to evaluate the clinical and radiographic outcomes of 3 different types of nonstandard glenoid components.
MATERIALS AND METHODS: Thirty-eight patients with a mean age of 65 years (range, 34-84 years) underwent a primary or revision anatomic shoulder arthroplasty with one of 3 nonstandard glenoid components: a polyethylene component with an angled keel for posterior glenoid wear without posterior subluxation; a polyethylene component with 2 mm of extra thickness for central glenoid erosion; or a posteriorly augmented metal-backed glenoid component for posterior glenoid wear and posterior subluxation. Average clinical follow-up was 7.3 years (range, 2-19 years) or until revision surgery.
RESULTS: At the most recent follow-up, 24 patients had no, mild, or occasionally moderate pain. Mean elevation improved from 91° to 126°, and mean external rotation improved from 24° to 53°. Thirteen patients had moderate or severe subluxation preoperatively, and 11 had subluxation at follow-up. On radiographic evaluation, 3 glenoid components had loosened and 3 were at risk for loosening at an average 5.5 years of follow-up. Seven patients had revision surgery: 4 for instability, 1 for osteolysis, 1 for component loosening with osteolysis, and 1 for a periprosthetic fracture. Three additional patients had removal of glenoid components, 2 for infection and 1 for loosening. Ten-year survival rate free of revision or removal of the angled keel component was 73% (95% CI: 75.3-70.7); of the extra thick (+2 mm) component, 69% (95% CI: 65-73); and of the posteriorly augmented metal-backed glenoid component, 31% (95% CI: 35.6-26.4).
CONCLUSIONS: The effectiveness of nonstandard glenoid components in addressing glenoid bone deficiencies is compromised by an increased rate of component loosening and by only partial success in eliminating subluxation.
Copyright © 2014 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Glenoid components; bone deficiency; shoulder replacement

Mesh:

Substances:

Year:  2013        PMID: 24332950     DOI: 10.1016/j.jse.2013.09.023

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  7 in total

1.  CORR Insights(®): posterior glenoid wear in total shoulder arthroplasty: eccentric anterior reaming is superior to posterior augment.

Authors:  Sergio Gutiérrez
Journal:  Clin Orthop Relat Res       Date:  2015-09-22       Impact factor: 4.176

2.  The arthritic glenoid: anatomy and arthroplasty designs.

Authors:  Nikolas K Knowles; Louis M Ferreira; George S Athwal
Journal:  Curr Rev Musculoskelet Med       Date:  2016-03

3.  Surgical management of the biconcave (B2) glenoid.

Authors:  Kenneth W Donohue; Eric T Ricchetti; Joseph P Iannotti
Journal:  Curr Rev Musculoskelet Med       Date:  2016-03

Review 4.  Shoulder resurfacing for treatment of focal defects and diffuse osteoarthritis.

Authors:  A Miniaci; M J Scarcella
Journal:  Orthopade       Date:  2021-02       Impact factor: 1.087

5.  Planning software and patient-specific instruments in shoulder arthroplasty.

Authors:  James D Wylie; Robert Z Tashjian
Journal:  Curr Rev Musculoskelet Med       Date:  2016-03

6.  Posterior glenoid wear in total shoulder arthroplasty: eccentric anterior reaming is superior to posterior augment.

Authors:  Tim Wang; Geoffrey D Abrams; Anthony W Behn; Derek Lindsey; Nicholas Giori; Emilie V Cheung
Journal:  Clin Orthop Relat Res       Date:  2015-08-05       Impact factor: 4.176

Review 7.  Custom-made reverse shoulder arthroplasty for severe glenoid bone loss: review of the literature and our preliminary results.

Authors:  G Porcellini; G M Micheloni; L Tarallo; P Paladini; G Merolla; F Catani
Journal:  J Orthop Traumatol       Date:  2021-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.